 A new wrinkle in the story of Amylyx Pharmaceuticals ongoing battle against ALS bodes well for patients, and for AMLX stock holders. The post Amylyx AMLX Stock Spikes 13 as FDA Resumes Discussion of ALS Drug appeared first on InvestorPlace. 